Hormone sensitivity is reflected in the phospholipid profiles of breast cancer cell lines

Breast Cancer Research and Treatment

Volumn 87, Issue 1, 2004, Pages 1-11

  Sterin, Marina ^a   Cohen, Jack S ^a   Ringel, Israel ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

31P MRS; Breast cancer; Phospholipids

Indexed keywords

ACYLPHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; PLASMENYLPHOSPHATIDYLETHANOLAMINE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE RESISTANCE; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; PHOSPHOLIPIDS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 4544278657     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000041572.07837.ec     Document Type: Article

References (55)

1. 31P magnetic resonance. Cancer Lett 176: 159-167, 2002
2. 31P NMR study. NMR Biomed 12: 184-188, 1999
3. 31P NMR phospholipid characterization of intracranial tumors. Brain Res 649: 1-6, 1994
4. 31P nuclear magnetic resonance spectroscopy. Lipids 29: 359-364, 1994
5. Aboagye E, Bhujwalla Z: Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 59: 80-84, 1999
6. 31P nuclear magnetic resonance study in vivo and in vitro. Magn Reson Med 41: 897-903, 1999
7. Clarke R, Thompson EW, Leonessa F, Lippman J, McGarvey M, Frandsen TL, Brunner N: Hormone resistance, invasiveness, and metastatic potential in breast cancer. Breast Cancer Res Treat 24: 227-239, 1993
8. Clarke R, Skaar T, Baumann K, Leonessa F, Lippman JM, Thompson EW, Freter C, Brunner N: Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression. Breast Cancer Res 31: 237-248, 1994
9. 31P-Magnetic Resonance Spectroscopy Study. Cancer Res 61: 7536-7543, 2001
10. Mardor Y, Kaplan O, Sterin M, J, R.-C, Ash E, Roth Y, Ringel I, Cohen JS: Intracellular cancer cell metabolism and response to lonidamine treatment using diffusion weighted proton MRS. Cancer Res 60: 5179-5186, 2000
11. 31P NMR studies. Breast Cancer Res Treat 33: 209-217, 1994
12. Katz-Brull R, Lavin P, Lenkinski R: Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 94: 1197-1203, 2002
13. Herminghaus S, Pilatus U, Moller-Hartmann W, Raab P, Lanfermann H, Schlote W, Zanella F: Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors. NMR Biomed 15: 385-392, 2002
14. Natarajan K, Mori N, Artemov D, Bhujwalla Z: Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression. Neoplasia 4: 409-416, 2002
15. Jagannathan N, Kumar M, Seenu V, Coshic O, Dwivedi S, Julka P, Srivastava A, Rath G: Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 84: 1016-1022, 2001
16. Ackerstaff E, Pflug B, Nelson J, Bhujwalla Z: Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res 61: 3599-3603, 2001
17. Katz-Brull R, Seger D, Rivenson-Segal D, Rushkin E, Degani H: Metabolic markers in breast cancer: enhanced choline matabolism and reduced choline-ether-phospholipid synthesis. Cancer Res 62: 1966-1970, 2002
18. Levenson AS, Jordan VC: MCF-7: the first hormone-responsive breast cancer cell line. Cancer Res 57: 3071-3078, 1997
19. Folch J, Lees M, Sloane-Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol. Chem 226: 497-509, 1957
20. Tyagi RK, Azrad A, Degani H, Salomon Y: Simultaneous extraction of cellular lipids and water-soluble metabolites: evaluation by NMR spectroscopy. Magn Reson Med 35: 194-200, 1996
21. 31P NMR of extracted phospholipids. J Lipid Res 29: 679-689, 1988
22. Willker W, Leibfritz D: Assignment of mono- and polyunsaturated fatty acids in lipids of tissues and body fluids. Magn Reson Chem 36: S79-S84, 1998
23. Rehman SU: Rapid isocratic method for the separation and quantification of major phospholipid classes by high-performance liquid chromatography. J Chromatogr 567: 29-37, 1991
24. 31P NMR at different compositions of the solvent system chloroform-methanol-water. Magn Reson Med 26: 46-59, 1992
25. Sparling ML, Zidovetzki R, Muller L, Chan SI: Analysis of Membrane-Lipids by 500 MHz H-1-Nmr. Anal Biochem 178: 67-76, 1989
26. Ferretti A, Knijn A, Raggi C, Sargiacomo M: High-resolution proton NMR measures mobile lipids associated with Triton-resistant membrane domains in haematopoietic K562 cells lacking or expressing caveolin-1. Eur Biophys J 32: 83-95, 2003
27. Pollesello P, Eriksson O, Kvam BJ, Paoletti S, Saris NEL: H-1-Nmr Studies of Lipid Extracts of Rat-Liver Mitochondria. Biochem Biophys Res Commun 179: 904-911, 1991
28. Van Blitterswijk WJ, Schaap D, van der Bend R: Generation and attenuation of lipid second messengers in intracellular signaling. Curr Top Membr 40: 413-437, 1994
29. Hurley JB. Signal transduction. Phospholipids in action. Nature 373: 194-195, 1995
30. Hurley JH, Tsujishita Y, Pearson MA: Floundering about at cell membranes: a structural view of phospholipid signaling. Curr Opin Struct Biol 10: 737-743, 2000
31. Snyder F: Ether-linked lipids and their bioactive species: occurence, chemistry, metabolism, regulation and function. In: Vance DE, Vance JE. (eds), Biochemistry of Lipids, Lipoproteins and Membranes, Vol. 31, pp. 183-209. Amsterdam-New york: Elsevier, 1996.
32. Cullis PR, Fenske DB, Hope MJ: Physical properties and functional roles of lipids in membranes. In: Vance DE, Vance JE. (eds) Biochemistry of Lipids, Lipoproteins and Membranes, Vol. 31, pp. 1-33. Amsterdam-New York: Elsevier, 1996
33. Lohner K, Balgavy P, Hermetter A, Paltauf F, Laggner P: Stabilization of non-bilayer structures by the etherlipid ethanolamine plasmalogen. Biochim Biophys Acta 1061: 132-140, 1991
34. 31P NMR. NMR Biomed 6: 187-193, 1993
35. Reiss D, Beyer K, Engelmann B: Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro. Biochem J 323: 807-814, 1997
36. Zoeller RA, Lake AC, Nagan N, Gaposchkin DP, Legner MA, Lieberthal W: Plasmalogens as endogenous antioxidants: somatic cell mutants reveal the importance of the vinyl ether. Biochem J 338: 769-776, 1999
37. Lee TC: Biosynthesis and possible biological functions of plasmalogens. Biochim Biophys Acta 1394: 129-145, 1998
38. Rapport MM. Reflections on the great plasmalogen puzzle: effector mediated signal transduction coupled to glyceride structures. Neurochem Res 23: 273-275, 1998
39. Perichon R, Moser AB, Wallace WC, Cunningham SC, Roth GS, Moser HW: Peroxisomal disease cell lines with cellular plasmalogen deficiency have impaired muscarinic cholinergic signal transduction activity and amyloid precursor protein secretion. Biochem Biophys Res Commun 248: 57-61, 1998
40. Yang HC, Farooqui AA, Horrocks LA: Plasmalogen-selective phospholipase A2 and its role in signal transduction. J Lipid Mediat Cell Signal 14: 9-13, 1996
41. Gaposchkin DP, Zoeller RA: Plasmalogen status influences docosahexaenoic acid levels in a macrophage cell line. Insights using ether lipid-deficient variants. J Lipid Res 40: 495-503, 1999
42. Spener F: Ether lipids in clinical diagnosis and medical research. In: Mangold HC, Paltauf F. (eds) Ether Lipids, pp. 239-259. New York: Academic press, 1983
43. Burt CT, J RH: A hypothesis: noncyclic phosphodiesters may play a role in membrane control. Biochem Med 31: 21-30, 1984
44. 31P magnetic resonance phospholipid profiles of neoplastic human breast tissues. Br J Cancer 63: 693-638, 1991
45. 31P magnetic resonance spectroscopy. Int J Colorectal Dis 6: 121-126, 1991
46. Killian JA, Koorengevel MC, Bouwstra JA, Gooris G, Dowhan W, Dekruijff B: Effect of divalent-cations on lipid organization of cardiolipin isolated from Escherichia-coli strain Ah930. Biochim Biophys Acta 1189: 225-232, 1994
47. Dekruijff B: Biochemistry - Polymorphic regulation of membrane lipid-composition. Nature 329: 587-588, 1987
48. Rietveld AG, Chupin VV, Koorengevel MC, Wienk HLJ, Dowhan W, Dekruijff B: Regulation of lipid polymorphism is essential for the viability of phosphatidylethanolamine-deficient Escherichia-coli-cells. J Biol Chem 269: 28670-28675, 1994
49. Dekruijff B, Cullis PR: The influence of poly(L-lysine) on phospholipid polymorphism - evidence that electrostatic polypeptide-phospholipid interactions can modulate bilayer-non-bilayer transitions. Biochim Biophys Acta 601: 235-240, 1980
50. Kester MB, Sokolove PM: The effect of adriamycin and duramycin on calcium translocation in liposome systems modeled on the inner mitochondrial-membrane. Arch Biochem Biophys 280: 405-411, 1990
51. Liang MT, Glonek T, Meneses P, Kopp SJ, Paulson DJ, Gierke LW, Schwartz FN: NMR spectroscopy study of heart phospholipids. An exercise and anabolic steroids effect. Int J Sports Med 13: 417-423, 1992
52. 31P NMR. Europ J Biochem 243: 328-335, 1997
53. 31P nuclear magnetic resonance. Lipids 33: 1023-1030, 1998
54. Stubbs CD, Smith AD: The modification of mammalian membrane poly-unsaturated fatty-acid composition in relation to membrane fluidity and function. Biochim Biophys Acta 779: 89-137, 1984
55. Heron D, Shinitzky M, Hershkowitz M, Samue ID: Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc Natl Acad Sci USA 77: 7463-7467, 1980